Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2014
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 25 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2013 Planned End Date changed from 1 Aug 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 14 Jul 2011 New trial record